Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Potenza Therapeutics

Potenza Therapeutics
2014 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
$165M LATEST DEAL AMOUNT
Description

Operator of a biotechnology company intended build a portfolio of oncology programs that utilize the body's own immune system to seek out, recognize and destroy tumors. The company's programs leverage novel biological insights into mechanisms by which cancer cells evade detection and destruction by the immune system, enabling medical practitioners to improve the health of patients through provision of innovative and reliable pharmaceuticals.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Primary Office
  • 1030 Massachusetts Avenue
  • Suite 210
  • Cambridge, MA 02138
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Potenza Therapeutics’s full profile, request a free trial.

Potenza Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Dec-2018 $165M 000 00000 Completed Generating Revenue
3. Early Stage VC 29-Dec-2017 000 000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 02-Mar-2016 $30M 0000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Potenza Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series AS 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Potenza Therapeutics Competitors (55)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
00000000 Venture Capital-Backed Tübingen, Germany 000 00000 00000000000 00000
0000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Potenza Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
CRV Venture Capital Minority 000 0000 000000 0
InterWest Healthcare Partners Venture Capital Minority 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0

Potenza Therapeutics Executive Team (11)

Name Title Board
Seat
Contact
Info
Daniel Hicklin Ph.D Co-Founder, Chief Executive Officer, President & Board Member
David Cordo Chief Financial Officer
Reid Leonard Ph.D Chief Operating Officer
Cynthia Seidel-Dugan Ph.D Chief Scientific Officer
Ana Anderson Ph.D Scientific Co-Founder & Member of the Scientific Advisory Board
You’re viewing 5 of 11 executives. Get the full list »

Potenza Therapeutics Board Members (5)

Name Representing Role Since Contact
Info
Arnold Oronsky Ph.D InterWest Partners Board Member 000 0000
Daniel Hicklin Ph.D Potenza Therapeutics Co-Founder, Chief Executive Officer, President & Board Member 000 0000

3 Former Board Members

You’re viewing 2 of 5 board members. Get the full list »